Galectin-1 overexpression in nasopharyngeal carcinoma: Effect on survival

Acta Oto-Laryngologica

Volumn 134, Issue 5, 2014, Pages 536-542

  Chang, Shih Lun ^a,d   Li, Chien Feng ^b   Lin, Charlene ^c   Lin, Yung Song ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Head and neck cancer; Survival rate

Indexed keywords

GALECTIN 1; LGALS1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CYTOPLASM; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SURVIVAL RATE; SYSTEMIC THERAPY; CARCINOMA; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; NASOPHARYNX; NASOPHARYNX TUMOR; PATHOLOGY; PROSPECTIVE STUDY; TAIWAN; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL LINE, TUMOR; FEMALE; GALECTIN 1; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; PROSPECTIVE STUDIES; TAIWAN; YOUNG ADULT;

EID: 84898015707     PISSN: 00016489     EISSN: 16512251     Source Type: Journal    
DOI: 10.3109/00016489.2013.868603     Document Type: Article

References (20)

1. Cedeno-Laurent F, Dimitroff CJ. Galectin-1 research in T cell immunity: past, present and future. Clin Immunol 2012;142:107-16.
2. Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006;16: 137R-57R. (Pubitemid 44530693)
3. Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, et al. Galectin-1:alink between tumor hypoxia and tumor immune privilege. J Clin Oncol 2005;23:8932-41. (Pubitemid 46211478)
4. Gillenwater A, Xu XC, el-Naggar AK, Clayman GL, Lotan R. Expression of galectins in head and neck squamous cell carcinoma. Head Neck 1996;18:422-32.
5. Saussez S, Camby I, Toubeau G, Kiss R. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head Neck 2007;29:874-84. (Pubitemid 350303676)
6. Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, Bravo A, et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege. Cancer Cell 2004;5:241-51. (Pubitemid 38402116)
7. Win KT, Lee SW, Huang HY, Lin LC, Lin CY, Hsing CH, et al. Nicotinamide N-methyl transferase over-expression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma. Tumour Biol 2013;34:3923-31.
8. Kao YC, Lee SW, Lin LC, Chen LT, Hsing CH, Hsu HP, et al. Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma. Tumour Biol 2013;34:759-68.
9. Cancer Registry Annual Report. Taiwan, ROC: Department of Health; 2009. https://cris.hpa.gov.tw/pagepub/Home. aspx?itemNo=cr.q.10.in Chinese last accessed October 28, 2013.
10. Chen L, Mao YP, Xie FY, Liu LZ, Sun Y, Tian L, et al. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol 2012; 104:331-7.
11. Sun DP, Lin CY, Tian YF, Chen LT, Lin LC, Lee SW, et al. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression. Tumour Biol 2013;34:3059-69.
12. Jung EJ, Moon HG, Cho BI, Jeong CY, Joo YT, Lee YJ, et al. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 2007;120:2331-8.
13. Kohrenhagen N, Volker HU, Kapp M, Dietl J, Kammerer U. Increased expression of galectin-1 during the progression of cervical neoplasia. Int J Gynecol Cancer 2006;16:2018-22. (Pubitemid 44924365)
14. Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH, Chen YC, et al. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncol 2008;44:325-34.
15. Szoke T, Kayser K, Baumhakel JD, Trojan I, Furak J, Tiszlavicz L, et al. Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer. Oncology 2005;69:167-74. (Pubitemid 41376916)
16. Grutzmann R, Pilarsky C, Ammerpohl O, Lüttges J, Böhme A, Sipos B, et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004;6:611-22. (Pubitemid 39411099)
17. Gabius HJ, Andre S, Gunsenhauser I, Kaltner H, Kayser G, Kopitz J, et al. Association of galectin-1-but not galectin-3-dependent parameters with proliferation activity in human neuroblastomas and small cell lung carcinomas. Anticancer Res 2002;22:405-10. (Pubitemid 34475330)
18. Tang CE, Tan T, Li C, Chen ZC, Ruan L, Wang HH, et al. Identification of Galectin-1 as a novel biomarker in naso-pharyngeal carcinoma by proteomic analysis. Oncol Rep 2010;24:495-500.
19. Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, Hong HC, et al. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res 2009;7:311-18.
20. Lin YS, Lin LC, Huang MH, Huang AJ, Huang YT. Down-regulation of gp130 in nasopharyngeal carcinoma. Am J Rhinol Allergy 2009;23:28-32.